In vivo assays corroborated this combined therapy effectiveness and demonstrated that CEA is an excellent tumor-specific promoter for targeting therapeutic genes expression within lung cancer cells inducing apoptosis and with no harm to normal cells (13). Here, CEACAM5 is linked to lung cancer.